干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
朗日生物

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
楼主: sunsong7
go

干掉你的不是埃博拉病毒本身 [复制链接]

Rank: 7Rank: 7Rank: 7

积分
13286 
威望
13286  
包包
34831  

论坛元老 精华勋章 金话筒 专家 优秀会员 优秀版主

11
发表于 2014-10-30 16:17 |显示全部帖子
这个是世界卫生组织官方网站的一个报道。标题《塞拉利昂:埃博拉幸存者痛苦延续》9 i) o& _. K) y  N' ^  ]- V7 d
http://www.who.int/features/2014/post-ebola-syndrome/en/index.html
. J  y0 ^8 ~# n
4 y7 y3 i/ B& O6 O+ BSierra Leone: for Ebola survivors the pain goes on[p=18, null, left]October 2014


) V3 e+ ^) ^4 d( Z' Y0 u

As the Ebola outbreak grows and spreads, a small but significant group of people is also growing - the Ebola survivors. Emerging shell-shocked from what one described as a "glimpse of hell", the survivors have not found life easy on the other side of the Ebola ward.

WHO/S. Gborie


; `# U' n: J0 A$ r* i- b& y

Ebola survivors tell their stories at the Survivors’ Conference in Kenema, Sierra Leone.


6 P; F# Z% `8 T' `


3 I+ l4 a; p* C6 U

Some in the community brand them as "witches" for surviving. For many, the faces they longed to see again while lying in the Ebola ward are no longer there. Husbands, wives, children, brothers, sisters, mothers and fathers have all been carried off to unmarked graves by Ebola virus disease.

“I am learning to live a new life in the home without my husband and my 2 children. Now there is so much emptiness in the house especially at night,” said Fatimata Gaima who clung to life in the hospital desperate to get home to care for her three year old.

However, as she recovered, her worst fears came true. Her last child was brought to the hospital ward, tested positive for Ebola, and died a few days later.

Survivors gather in Sierra Leone

Ms Gaima told her story to others in a small focus group at the first Ebola survivors conference organized by UNICEF and GOAL, humanitarian agency, in Kenema, one of the areas where the Ebola outbreak first exploded in Sierra Leone. The meeting aimed to identify the needs of survivors – physical, mental, social and economic – and help them to consider how they might contribute to battling the Ebola virus outbreak in Sierra Leone.

Services for survivors are gradually emerging. At one post-Ebola clinic, set up to deal with survivors’ psychological and social needs, it has become evident that physical after-effects of the disease are among the most pressing problems Ebola survivors face.

"I am learning to live a new life in the home without my husband and my two children."

Fatimata Gaima, Ebola survivor in Sierra Leone


; s) O, h4 Q( \6 c5 n

“We are seeing a lot of people with vision problems,” says Dr Margaret Nanyonga, psychosocial support officer for the World Health Organization in Kenema. “Some complain of clouded vision, but for others the visual loss is progressive. I have seen 2 people who are now blind.”

Dr Nanyonga said that people with what she calls "post-Ebola syndrome" have a range of symptoms. These have been seen in survivors of previous outbreaks and cause long-term disability. Apart from visual problems which affect approximately 50% of Ebola survivors in Kenema, people complain of "body aches" such as joint, muscle and chest pain. They also suffer headaches and extreme fatigue, making it difficult to take up their former lives – especially if it involved manual work – as farmers, labourers and housewives.

WHO/S. Gborie


; b" V0 s/ K( H' o4 L. i, T

Fatimata Gaima at the Survivors’ Conference,
9 C) t5 O; a/ e& M, @$ qKenema, Sierra Leone.

, A6 @0 S. R8 J. P5 |
* Q3 j7 I; u1 J( C; s
Need for more information on post-Ebola syndrome

“We need to understand why these symptoms persist, whether they are caused by the disease or treatment, or perhaps the heavy disinfection,” says Dr Nanyonga who has developed an assessment tool that will be used to establish the most common and disabling symptoms and what can be done to help survivors with these problems.

Dr Andrew Ramsay, field coordinator for WHO in Kenema, says it is essential that potentially disabling physical and psychological problems be diagnosed and, where possible, treated as quickly as possible.

“Eye problems might be caused by damage to the cornea, to the nerves or something else. At this point we do not have enough information to know exactly what is going on. But we need to find out urgently so we can do whatever we can to preserve the eyesight for people who have to try to pick up their lives again.”

Rank: 7Rank: 7Rank: 7

积分
13286 
威望
13286  
包包
34831  

论坛元老 精华勋章 金话筒 专家 优秀会员 优秀版主

12
发表于 2014-10-31 10:35 |显示全部帖子
日研究员称埃博拉出血热症状不同或因个体基因差异5 `$ n1 X' K% _8 N3 f
2014-10-31 10:15:00 环球网 马丽
" N+ Z- w% [4 Q3 h   【环球网报道 实习记者 马丽】据日本《东京新闻》10月31日报道,美国华盛顿大学日本籍研究员奥村敦及美国国立过敏感染病研究所团队,30日在美国科学杂志电子版上发表称,在白鼠试验中,两只白鼠均感染埃博拉病毒,病发死亡的白鼠与病后康复的白鼠在肝脏及脾脏等的基因功能上存在差异。* {' L8 z- w1 D
  据报道,此项研究表明,生物体内与血管修复及免疫功能相关的基因“Tie1”与“Tek”,可能对出血症状有抑制作用。西非埃博拉病毒肆虐,人们患有埃博拉出血热后症状上却存在明显不同,个人体内基因差异可能是其原因之一。研究员奥村表示“这似乎在对人体不同症状解析上提供了线索”。, l# [' U- z7 S% H
6 W- ~. B0 ?0 K6 ~

Rank: 7Rank: 7Rank: 7

积分
13286 
威望
13286  
包包
34831  

论坛元老 精华勋章 金话筒 专家 优秀会员 优秀版主

13
发表于 2014-10-31 10:39 |显示全部帖子
年龄和基因影响埃博拉患者存活率2 c0 k. y9 G$ X) Z. ?
2014-10-31 09:44  来源: 新华社       
7 G; ]- Y$ p& t  新华社华盛顿10月30日电(记者林小春)什么因素影响着埃博拉患者的生与死?首当其冲的是年龄。一项在塞拉利昂的实地观察发现,与老年人相比,年轻人更容易战胜埃博拉病毒。但基因影响也不容忽视,一项小鼠实验显示,如果某些人促进血管修复和免疫力的基因比较活跃,那么他们的病情会相对较轻。  q5 `! O1 R) {! ~0 g3 ?
9 x. R& s% w8 Y, M5 @
  新一期美国《新英格兰医学杂志》发表了一些医护人员在塞拉利昂某医院的观察结果,他们共接诊了213名出现埃博拉症状的病人,其中有106人被确诊感染埃博拉病毒。这说明在西非疫区,很难通过症状判断一个人是否为埃博拉患者。" h* {! H0 E1 `! P) }9 O/ k( ?( i

2 ~% F5 O+ N# X/ ]$ V2 ^) |& g0 `  研究表明,上述埃博拉患者的潜伏期通常为6到12天,与此前的观察结果相似。在研究过程中,19人失去联系,其余87名病人中不治身亡者约占74%。幸存者中,21岁以下患者的死亡率为57%,而45岁以上患者的死亡率高达94%,介于两者之间的患者死亡率为74%。性别对死亡率似乎没有影响。
( S$ p* N, I$ @' j3 Q
( S( M; Z. V% o+ Z( q  患者的常见症状有发热、头疼、乏力、眩晕、腹泻、腹痛、咽喉痛、呕吐和结膜炎,仅有1名患者出现出血症状。其中与死亡最相关的症状是腹泻,腹泻患者的死亡率为94%,无腹泻的患者死亡率是65%。研究人员说,这说明及时输液补充电解质的重要性。此外,患者血液内病毒越多,病情就越严重,越容易死于埃博拉。
4 i! l& |. F0 _; Q1 w$ c1 E; @+ x* N( D& s' {8 D0 i
  在这篇论文的47名参与研究者中,有6人因感染埃博拉病毒死亡,还有1人死于中风,这再次凸显在一线抗击埃博拉的医护人员所面临的高风险。7 p: i( u( |9 B& K  D; `

& ^& m8 H8 F- p1 F+ ~. \  美国华盛顿大学等机构研究人员30日在《科学》杂志上发表的研究结果显示,基因也会影响埃博拉患者的存活率。
; C7 s/ O4 Q7 r* [0 |- z
3 y+ a6 d3 c2 F  此前埃博拉研究多使用猴子,但新研究在最高防护等级的实验室中培育出了一种可用于埃博拉研究的小鼠。在实验中,70%的小鼠感染埃博拉病毒后出现症状,其中超过一半死亡;19%的小鼠感染后体重下降,但两周后自行康复;另有11%的小鼠对埃博拉病毒有部分免疫抵抗力,其中不到一半死亡。这与目前西非的埃博拉疫情特点类似。! R' @9 P5 s* F$ \! l: a7 V/ V

  \! J( O* `: D0 x" x2 M5 |/ `  进一步研究表明,上述幸存小鼠的TIE1基因和TEK基因比较活跃,这两种基因会促进血管修复和抗感染白细胞的生成。而死亡小鼠体内促进血管炎症和细胞死亡的基因比较活跃。
6 U! c# _7 P0 d7 J
5 C; |# f0 z' R" k  负责这一研究的华盛顿大学病毒学家迈克尔·卡茨在一份声明中说:“我们的数据表明,基因因素对埃博拉病情的结果发挥着重要作用。”

Rank: 7Rank: 7Rank: 7

积分
13286 
威望
13286  
包包
34831  

论坛元老 精华勋章 金话筒 专家 优秀会员 优秀版主

14
发表于 2014-10-31 10:54 |显示全部帖子
干细胞之家微信公众号
几内亚埃博拉幸存者加入救援 可不穿防护装备( X( Y, |$ I  O1 b6 T8 \9 i

6 t/ o$ g! r% H/ z; @2014-10-29 20:15:00 来源: 环球时报-环球网(北京)
( V) H" w& I, C0 U0
2 A: F' v5 Y% h0 d5 D3 F0 R【环球网综合报道】据英国路透社10月28日报道,几内亚中学教师芬达·卡马拉(Fanta Oulen Camara )是埃博拉幸存者之一。然而,战胜病魔的喜悦没有维持多久,随之而来的却是遭遇孤立和驱逐。近日,与卡马拉有相同遭遇的幸存者们加入了几内亚某协会,旨在帮助埃博拉幸存者们维护利益,并寻找方法抗击埃博拉疫情。$ b) m/ J1 n( a& L6 x% g& l
: Z! a+ }6 N% S9 C; d
据报道,现年24岁的卡马拉已经已经经历了6位亲人因病魔而离去,他现在在几内亚首都医疗慈善机构“无国界医生组织”工作。8 ^0 y0 C/ A, y" k( H+ A
* K" i) A9 F- T+ s6 K; i- G
埃博拉幸存者们被认为血液中存有埃博拉的抗体。由于该病毒通过患者体液传播,普通治疗人员需要穿戴笨重的防护装备防止与患者身体直接接触。但是埃博拉幸存者们却可以不用穿。7 h: r8 o; s1 Y# ~4 X  h: ~

3 \1 v4 E/ X. |# a7 v& k埃博拉幸存者们的血液有望成为抗击埃博拉的血清来源。利比亚计划开始储备埃博拉幸存者血液,世界卫生组织(WHO)表示,此项治疗最早可在12月进行。( k6 X: l" h7 F) q

6 \4 t! k& I' {4 d# C4 A(原标题:几内亚埃博拉幸存者加入救援 血液有望抵抗病毒)

Rank: 7Rank: 7Rank: 7

积分
13286 
威望
13286  
包包
34831  

论坛元老 精华勋章 金话筒 专家 优秀会员 优秀版主

15
发表于 2014-11-4 22:30 |显示全部帖子
埃博拉传染力不会增强 患者年龄越大死亡率越高
+ V1 \0 _; F( b! \  t; Q/ A! t
) K; K  S, ], v
; n" S  F1 [( V* G' O2014年11月04日 18:07  来源:天山网 . O/ U' a( H: r6 P
  J/ k) A/ f2 X' Y& ^- B: p
www.ts.cn 天山网   2014年11月04日 18:06:22  
+ g+ h( L$ ^4 L9 u1 f2 w
, H  K% d( m1 K& E* o' ]. [中新网11月4日电 人们对正在西非等地肆虐的“埃博拉病毒”的认识正在不断加深。日本《经济新闻》4日刊文,虽然传染力等病毒的性质和过去相比没有发生变化,但是因患者年龄和治疗状况不同治疗效果会出现差异。
. N" O, ]& I9 @8 D! {2 e- k/ n
, x( D, L5 J% D: t" A文章援引专家观点,预计病毒的传染力今后不会增强,如果能通过隔离患者等举措来降低接触感染的风险,则能够抑制埃博拉出血热蔓延的态势。! j6 R* s- l6 E: D
7 C9 q9 U/ |! y1 ]6 f  b0 D1 I
尚无变异的证据
- B# S2 c$ z$ C# c3 K
- g, ~: |0 |: i& T: L  e2 p文章指出,埃博拉病毒为长约1微米(微米为百万分之一米)的带状病毒,通过血液等感染后将向细胞传递RNA(核糖核酸),也被称为“RNA病毒”,与流感病毒属于同一种类。7 o' h" q0 S4 H, ?+ V) o/ a
; x3 b( A4 h. l& G% U6 l
专家认为,病毒经过多次感染后会发生变异,但是病毒的性质本身和原来相比没有发生变化。致死率方面,包括疑似病例在内的致死率约为50%,而只计算确诊病例的致死率则高达70%以上。) ?5 _8 N  W. B( F: L

  x# F( J$ k6 E* s埃博拉病毒共有5种,此次确认的是“扎伊尔型”。扎伊尔型埃博拉病毒此前曾在中非地区爆发过,致死率最高达到90%,但是此次的致死率仍比过去稍微低一些。日本国立感染症研究所病毒1部的西条政幸部长表示“与中非不同,应该是西非的扎伊尔型病毒吧”。
- }# M% V- Q' i( l  I! A: n& a# w& x9 X- H$ n
此次的爆发规模比过去大的主要原因是,在人口较多的城市地区感染人数出现增多。目前尚无证据证明随着病毒的变异,传染力出现增强。部分医生担心埃博拉病毒能像流感病毒一样通过唾液等“飞沫传播”,但是国立国际医疗研究中心的护士堀成美称“如果通过飞沫传播,从流行病学的角度来看,应该有更多患者染病”,持否定观点。
- J& t) D$ ~7 w& j- P; f0 v9 H: C# ?' |0 `
有人因疾病而死亡,另一方面,约半数患者将恢复健康。美国杜兰大学等对埃博拉持续流行的塞拉利昂的106位患者进行分析后发现。根据接受治疗时的病人血液中的病毒量的不同,致死率存在差异。
, `; N% n' Q; B9 Z3 h0 |6 G0 _
+ c" I9 ]2 O* r) e0 k( h如果每毫升血液的病毒低于10万个,致死率仅为30%;但如果高于这个数字,致死率将超过70%。杜兰大学的谢非林(John Schieffelin)助教表示,“如果在发病后尽早治疗,生命将能够得到挽救”。
$ _/ x  d( o3 ^; F9 t0 u7 ^; @/ V# U
46岁以上致死率达90%
/ _: j; N3 \1 C% E) ?
2 |* m. q! m: p- f7 I1 Y5 T! W8 J8 T/ U! d
文章称,患者年龄越大致死率越高。在20岁以下,致死率不到60%,而46岁以上则超过90%。谢非林助教表示,“老年人经常患有的糖尿病和高血压等疾病以及免疫力可能造成影响”。出现头晕和腹泻症状的患者的病情都很严重。+ F- {4 J! \) i3 F: n+ {
7 I: e0 T4 N8 R( p& D# q5 t, \; ~
有研究表明,由于决定体质的基因的不同,症状的严重程度也不同。基于小鼠试验中,美国国家过敏及传染性疾病研究院(NIAID)的奥村敦研究员等人在美国《科学》杂志上发表论文称,观察感染埃博拉病毒但症状较轻的小鼠发现,修复血管基因的作用很大。奥村研究员表示,“可能有人在遗传上抵抗力较强”。
2 S. p: s! T, ]: t& m9 R1 _/ \( B
6 W1 h, P+ L8 o. ]% z1 e世界卫生组织(WHO)10月29日宣布,“新增感染有可能正在减少”。有分析认为这是因为应对措施发挥了效果。谢非林助教指出,“要根治埃博拉,需要尽早发现感染者并加以隔离,采取适当的医疗措施。这将是漫长的道路”。毫无疑问将成为长期战斗。

Rank: 7Rank: 7Rank: 7

积分
13286 
威望
13286  
包包
34831  

论坛元老 精华勋章 金话筒 专家 优秀会员 优秀版主

16
发表于 2014-11-4 22:57 |显示全部帖子
本帖最后由 sunsong7 于 2014-11-4 23:04 编辑 + }5 A/ S, C% r* ~+ `$ \5 z) r
' x8 Q3 t/ c. B6 t# v: ^1 D8 w& l! N
Study: Young people more likely to survive Ebola. T  X8 N9 l9 f) T
5 v3 I: u5 Q9 j! d1 f! b% c
2 N! {( z: Z( ]8 ]! C) ^
AP 8 p.m. EDT October 29, 20148 F" B3 C& T" d1 p8 o5 j
- g( x5 E' w7 G! c9 S
Who survives Ebola and why? Health workers treating patients in Sierra Leone, including some who died doing that work, have published the most detailed report yet on medical aspects of the epidemic. The research suggests young people are less likely to perish, fever is the most common symptom when victims first seek care, and early help is crucial.# ]0 f, y# Z! }; [
5 _' s' @5 H% W1 p) }/ }, l; O" ]
The report, published online Wednesday by the New England Journal of Medicine, is from 47 doctors, nurses and others who cared for 106 patients at Kenema Government Hospital in Sierra Leone, one of the West African countries hardest hit by the Ebola epidemic.7 n$ q" w0 c0 C9 F1 h

9 T5 h4 t) \0 `# m; Y, sTheir work adds new knowledge about the disease, which has killed more than 5,000 since early this year,the largest outbreak ever of Ebola, said one study leader, Dr. John Schieffelin, an infectious diseases specialist from Tulane University School of Medicine.
4 e5 X  e, Y, _
8 k: E2 i. Y8 G1 U2 W( `2 oEBOLA: IRS gives tax relief to victims1 S$ t7 ^" g6 w% n  S5 m/ N/ f

3 S4 P4 p. ~/ ^8 R* R- k# |In particular, it shows the advantage of youth — the fatality rate was only 57 percent for patients under 21, but a whopping 94 percent for those over 45.. t7 e' ^3 H& ]9 B

0 T0 u; M; `7 _% J+ w1 I"They're more resilient and younger and tougher," Schieffelin said.
% Y4 \; b- i# N
, {( h% _1 I$ z0 F"This is definitely the most detailed analysis" of symptoms and factors related to survival, he added.& G( s" B8 r' C+ A- }
5 `2 ^- Y3 X6 ^" [+ c
One striking factor was how devastating the severe diarrhea is from the disease.
* M+ U+ W5 U3 K0 J+ ?; S7 T8 J  M
1 A% F$ p: k  Y1 @; o2 j"It requires a lot of intensive fluid therapy," and replacement of body salts called electrolytes, to help people survive, he said.
; l* M7 }' Z' e( {$ y5 d( a6 i; b! @; @  v( F
Key findings:
7 M5 i  W& r9 S8 @2 |0 Q9 U8 K0 I' A1 p9 A" K: _+ P! D: B
It can be hard even in an outbreak setting to tell who has Ebola. Of the 213 people initially tested for signs of a hemorrhagic fever, about half, or 106, turned out to have Ebola.: {% P9 y: I2 Y. l
The estimated incubation period was 6 to 12 days, similar to what has been seen elsewhere in this outbreak.9 T: y, k6 T" A" h
Fever was the most common symptom — 89 percent had it when diagnosed. Other symptoms were headache (80 percent), weakness (66 percent), dizziness (60 percent), diarrhea (51 percent), abdominal pain (40 percent), and vomiting (34 percent). Only one patient had bleeding, one of the most gruesome symptoms, but researchers say other cases may have been missed through incomplete record-keeping. Patients with weakness, dizziness and diarrhea were more likely to die.& [/ u: s+ {3 H7 Y/ @5 V; w
Those with more virus in their blood when they sought medical care, indicating more advanced infections, were more likely to die than those who got help when their illness was less far along.$ C" I7 `/ N4 L# i; w/ D
Seven of the 47 study authors died — six of them from Ebola and one from a stroke. They included Dr. Sheik Humarr Khan, a doctor who led Sierra Leone's battle against Ebola until his death in July.
& E' [# K# W$ o9 F
/ H. C: f: V0 H8 bhttp://www.usatoday.com/story/news/world/2014/10/29/ebola-study-young-people/18139135/
5 ]6 j) V( i9 Q' s' {4 ~' J- ?1 ~5 I& g4 a$ t& N

0 G$ N7 C) |+ i4 O! tShe survived. He died. Why can some people beat Ebola?
' Z1 O6 O/ ]' e1 s+ V
/ b8 ~2 ^1 _7 OIs it genes? Is it age? Competing studies examine the issue/ A$ P. a. d9 B: @% Z$ d6 E

7 u0 o) t7 e! d; O10:23 AM - October 31, 2014
2 z# J4 C+ @1 F' E% i9 m) F' V" H
One challenge facing public health officials is that the Ebola virus seems to strike unpredictably, with some family members surviving the virus—or not even contracting it at all—even as their siblings or parents die from it.
6 k, s9 H2 ]9 _! T3 b( y" e# @" u4 _, X* H7 g# ^
A pair of studies published in the New England Journal of Medicine and Science, respectively, examine why some people are more prone to contracting Ebola than others, and, among those who do develop the virus, why some have a greater risk of dying.' n" Y% ]# s0 F2 i, k& J4 R" j4 f

1 P2 z% |) Z& }- w
" H( V. r2 w1 G( q: l3 [Four maps that explain the Ebola outbreak / Y( g1 m3 J" ~+ I/ \( O7 G
Age, early diagnosis keys to Ebola survival, NEJM study finds# A$ `" }$ {$ N8 I8 E) Z3 h

6 s4 k. W# G; T3 V7 |The first study examined data from 44 patients diagnosed with Ebola in Sierra Leone's Kenema Government Hospital from May 25 to July 18.7 F! y: c# |, M4 q8 g/ I2 _
/ L: S- F" V' z
This is the first time anybody has had this much data collected on any Ebola patients," says John Schieffelin of New Orleans-based Tulane University, one of the study authors. (Six of the 47 study authors died from Ebola.)  j) F& I4 d0 a3 V* p
9 E& M* T+ U. V2 I
The study found that in all cases studied, the virus took about six to 12 days to incubate and about 74% of those infected died. However, the age of the infected person and the pace at which the Ebola virus replicated within the person's body were found to play a significant role in whether he or she survived. Specifically, just 57% of infected persons under age 21 died, compared with 94% of those over age 45.
% U+ n# Q* Q/ d" X8 W, C# w/ S; E( g1 H2 w
What's more contagious than Ebola? Panic. 8 s/ W. i0 R* p' q8 H# {

) _. p& C6 q5 R4 p! J! ASimilarly, 33% of patients with fewer than 100,000 copies of the virus per milliliter of blood at diagnosis died, while 94% of individuals with more than 10 million copies of the virus per milliliter of blood at diagnosis did so. Thus, those who were diagnosed early on had a greater chance of survival.3 E! G, d, q: ]# q7 |
4 u8 f8 h5 ~6 V- R# l& A
The researchers also looked at the symptoms that patients with the virus experienced, and found that:
- H9 ]* K5 q9 n: t8 t  }: r: C
5 H+ Y& P/ P9 F& U6 |& b89% of patients experienced a fever;
# }$ q$ _2 }# _8 Z4 k$ l6 V, f80% had a headache;
7 H. H' n& l7 M. Y66% felt weak;: S2 k8 x, R1 r1 l
60% felt dizzy;$ W& J# p6 A3 M/ K' f! A, O! j
51% had diarrhea;
# x' [5 h$ p& @9 X3 G& U$ d40% experienced abdominal pain; and
  k6 D  Q3 {3 w34% experienced vomiting.) c; h0 K- J& O* D
Just 1% of patients experienced bleeding, which had been a key feature of the virus in previous Ebola outbreaks.# l6 n& `- o5 @/ L/ _; g& \
' E0 T8 A( s; b7 l+ G! Z- N
WANT TO STAY UP TO DATE ON EBOLA NEWS?7 r: \8 |: r" Q5 {

5 _' n5 [' e1 o6 \8 HSubscribe for our Ebola Alerts now
' A% W8 H! b8 X* }/ gAccording to Scheiffelin, diarrhea was a "really big feature of" the virus in the patients studied and caregivers should be aware of this and be aggressive in administering intravenous fluids.- y) t; `( c' l3 g

, h. t& x8 b  S, JWhile some observers have questioned the necessity of allocating resources to such a study during the middle of an outbreak, the researchers defend their analysis and note that the information gathered will help health care workers currently fighting the outbreak to develop new diagnostic approaches based on data.
0 w. K; f6 ~  Q* e; q
# V9 w  B5 e3 D- X9 e% M5 L" @: zNew York City confirms its first Ebola case. Mayor: 'There is no cause for alarm.' . m0 Z! a/ d! m( R7 Q8 z4 p7 d

- w0 n: s2 K$ D) p7 D1 g/ Q! cCould contracting Ebola be based on genetics? Science study examines. c$ S# w- `4 g! G1 n) j. L

' Q9 y. d! d- v0 t5 E  I, ?A second study conducted by researchers from the University of Washington, the University of North Carolina, and the National Institutes of Health in Montana examined mice to find out if their genetics played a role in the likelihood of them contracting the disease.
# Y3 G. @/ h+ x3 t# h6 |1 {
* \$ v2 D: _3 iFor the study, the mice were all injected with the same strain of virus that is currently plaguing West Africa. All of the mice lost weight within the first few days after injection. However, nearly 20% of mice regained that weight within two weeks and did not develop symptoms of the disease.6 D3 ]. ?3 [% [4 N

% b+ d$ h9 z' l* C6 }4 l9 iEbola in the U.S. is worrying. But in West Africa, the situation is downright dire.
% ~( H& ~- V& N+ x1 F, y9 u) n) A! a8 l. D, R
Contrastingly, about 70% of mice became very sick, showing symptoms of liver inflammation., Even more had issues with blood clotting, internal bleeding, and swollen spleens. Such mice had about a 50% chance of dying from the virus.
7 g& x& V- u" d0 E9 |1 L
& w- g$ ^2 f( G  r  uAccording to the researchers, the reason some mice remained immune to the deadly virus was because of how the disease reacted to the specific hosts' genes—something also seen in many other viruses.
' R) j' }6 R, X/ \# Q4 E2 X! L& H( y; h$ @3 V
Jonathan Ball, professor of molecular virology at the University of Nottingham, calls the study "intriguing," but notes that the association of the mice's genes and how the virus affected them "needs to be explored more to know definitively how expression is controlled and how it might influence the disease."6 K: o4 e% @8 v0 a' A
1 F# Q: j/ I( C) L) ?/ h
However, Andrew Easton, a virology professor at the University of Warwick says the study could not be directly be applied to humans because our genetic makeup is much more complex than that of mice. Additionally, he notes, the study did not assess the role environmental factors played.
' m- }2 s: Q. W* u5 K# r
' c& B( {6 u  t( r' rEaston did note that the data show it "may not be necessary to completely eliminate Ebola virus from the body during infection to ensure there is no disease, and that reduction of virus growth in the body may offer alleviation from some aspects of the disease." That natural reaction may reduce the pressure on new treatments to be thorough (Steenhuysen, Reuters, 10/29; BBC News, 10/30).9 S& a# i: }7 R0 [5 B

$ [( Z8 R  m* h! g, ?, G, e# Shttp://www.advisory.com/daily-briefing/2014/10/31/why-some-people-can-beat-ebola
2 k1 K! a. n2 C# B2 V  H/ k! r( Y$ v, D7 B$ i$ P
[size=1.083em]Friday, October 31, 2014, 00:01 by Julie Steenhuysen, Reuters% s9 l8 a* M% ]& I8 h6 R' `& z
Why do some survive Ebola?Sierra Leone study provides some important clues as to how virus kills; Z8 F4 ^& V4 g0 H: C% |

Masks used by volunteers who will be sent to Africa. Photo: Philippe Wojazer/Reuters

An analysis of the first Ebola cases in Sierra Leone helps draw a clearer picture of why some people survive the disease, while others do not, including their age and the pace at which the virus replicates within their body.

The study is based on data gathered from 106 patients diagnosed with Ebola at the Kenema Government Hospital in Sierra Leone from May 25 to July 18. Some of the data on this group was incinerated because of fears that the nurses’ station where the records were kept became contaminated.

But the team managed to analyse detailed clinical records from a total of 44 Ebola patients, the biggest trove yet from the outbreak in West Africa that has killed nearly 5,000 people.

[size=1.5em]74 per cent of the patients in the study died, similar to what has been seen in prior outbreaks
$ Y) U. L% X, Q  n; n9 b' ~% y- Y; ~: ?
6 }' R5 B1 R, K' ^1 E

“This is the first time anybody has had this much data collected on any Ebola patients,” said John Schieffelin of Tulane University in New Orleans, an author of the study published in the New England Journal of Medicine.

He said the findings help confirm some of the observations seen by doctors treating patients with Ebola.

It shows, for example, that 57 per cent of people under age 21 who were treated for Ebola died from their infections, compared with 94 per cent of those over the age of 45.

In the cases studied, the virus took six to 12 days to incubate before patients developed symptoms, and 74 per cent of the patients in the study died, similar to what has been seen in prior outbreaks.

[size=1em]A man looking after his children as they await transport to the holding centre in the Port Loko Government Hospital in Sierra Leone. Photo: Christopher Black/Reuters/WHO

4 V8 M! p& Z$ l# t- W: R* _! X; G/ h

Fever was the most common symptom, occurring in 89 per cent of patients, followed by headache (80 per cent), weakness (66 per cent), dizziness (60 per cent) diarrhoea (51 per cent), abdominal pain (40 per cent) and vomiting (34 per cent). However, there were some big differences in how individual patients responded to the virus, Schieffelin said. One surprise was the significant difference in the amount of virus present in patients when they came in for treatment, a factor that affected whether or not they survived.

For example, 33 per cent of patients with less than 100,000 copies of the virus per millilitre of blood at diagnosis ultimately died, compared with 94 per cent mortality in those whose hadmore than 10 million copies per millilitre.

Among the various symptoms in this outbreak, Schieffelin said diarrhoea is a “really big feature of it”, suggesting that doctors treating Ebola patients need to be very aggressive in administering intravenous fluids.

Bleeding, a key feature of Ebola in prior outbreaks, was rare among this population, with only one patient having this symptom, the study found.

Some researchers have questioned the value of spending resources on studying Ebola during the outbreak rather than using those funds to help curb the epidemic directly.

Schieffelin said the analysis offers important insights for healthcare workers fighting the current outbreak, including data that can be used to determine new treatment and diagnostic approaches.


% P; H8 a% }. ~- q

http://www.timesofmalta.com/articles/view/20141031/world/Why-do-some-survive-Ebola-.542048


- q  W7 h/ X  s9 c


( A9 r% }2 i. a5 ]: {7 l

Why do some survive Ebola? Sierra Leone study offers cluesBY JULIE STEENHUYSEN9 L2 B# R( v# g! `6 H
Wed Oct 29, 2014 5:00pm EDT$ s; x' @" |  m
8 Y8 [- t# T+ c/ V* L
+ n4 ^; k6 U$ I& r+ q  ~
(Reuters) - An analysis of the first Ebola cases in Sierra Leone helps draw a clearer picture of why some people survive the disease, while others do not, including their age and the pace at which the virus replicates within their body.  V0 T: y: E7 z7 D& Q- L
$ ]: U9 p. P+ L' L
The study published Wednesday is based on data gathered from 106 patients diagnosed with Ebola at the Kenema Government Hospital in Sierra Leone from May 25 to July 18. Some of the data on this group was incinerated because of fears that the nurses' station where the records were kept became contaminated.5 Z, @' F# X$ m$ a/ D/ L+ {; c% w
$ ^4 ~, v* _- N
But the team managed to analyze detailed clinical records from a total of 44 Ebola patients, the biggest trove yet from the outbreak in West Africa that has killed nearly 5,000 people.+ M7 ~4 \3 G/ Q1 u5 v
2 |) _) t2 r8 Z' H9 u5 i
"This is the first time anybody has had this much data collected on any Ebola patients," said Dr. John Schieffelin of Tulane University in New Orleans, an author of the study published in the New England Journal of Medicine.4 c- R/ l3 ^- ?4 k0 ^

$ ^7 ?, Y% B% R8 v+ Y0 lHe said the findings help confirm some of the observations seen by doctors treating patients with Ebola.
) L7 o8 L8 ^4 j. S" n* M  b; ?7 L0 [
It shows, for example, that 57 percent of people under age 21 who were treated for Ebola died from their infections, compared with 94 percent of those over the age of 45.6 c9 c8 l3 |2 C/ S2 g; G

: N4 M( O2 y2 ]8 l9 I* H+ W+ H, CIn the cases studied, the virus took six to 12 days to incubate before patients developed symptoms, and 74 percent of the patients in the study died, similar to what has been seen in prior outbreaks.
+ z" ~) H3 y+ K# P
, Z3 o) M, M; |' N6 B) m9 B2 `' J+ O7 uFever was the most common symptom, occurring in 89 percent of patients, followed by headache (80 percent), weakness (66 percent), dizziness (60 percent) diarrhea (51 percent), abdominal pain (40 percent) and vomiting (34 percent).* G, [0 x, G2 n% W, L" H/ x3 Z# m

/ N! i0 H& ~# X8 E4 u+ J( a7 gHowever, there were some big differences in how individual patients responded to the virus, Schieffelin said.6 |4 _+ M& `' P. c3 B+ |

" S+ l5 F3 M+ r" I$ G( J" `"There were people who had very mild cases, and there are people who have very severe cases and they go downhill quickly," he said.
; m% @' k2 p  J
- @! A7 Q; X" E7 m1 |* E6 }; {! WOne surprise was the significant difference in the amount of virus present in patients when they came in for treatment, a factor that affected whether or not they survived.
) e: o! M: @6 I7 v$ ~' E/ f
: G; j- {" v/ zFor example, 33 percent of patients with less than 100,000 copies of the virus per milliliter of blood at diagnosis ultimately died, compared with 94 percent mortality in those whose had more than 10 million copies per milliliter.
5 J- l0 Z% J6 r) v1 p! a
3 z1 R0 x6 p. O5 fAmong the various symptoms in this outbreak, Schieffelin said diarrhea is a "really big feature of it," suggesting that doctors treating Ebola patients need to be very aggressive in administering intravenous fluids.1 v- E& {* g# `( M
) W$ i9 {/ }, s$ z5 d
Bleeding, a key feature of Ebola in prior outbreaks, was rare among this population, with only 1 patient having this symptom, the study found.
( }! f7 X' `6 M* s2 q: ]: W# o- \5 j3 h# O* ~
Some researchers have questioned the value of spending resources on studying Ebola during the outbreak rather than using those funds to help curb the epidemic directly. Schieffelin said the analysis offers important insights for healthcare workers fighting the current outbreak, including data that can be used to determine new treatment and diagnostic approaches.
+ Y5 M* I, B% P$ \; h% J/ a1 [2 v9 g( r" c( E2 {
(Reporting by Julie Steenhuysen; Editing by Jonathan Oatis)
7 P. `) m. n  z1 ?. E; ?) N; h% b* O6 p# |; v5 x$ C' H1 W" |
[p=23, null, left](Reporting by Julie Steenhuysen; Editing by Jonathan Oatis)' F) Q$ t% {9 p' ^2 Y" e. I

! T2 R( K( \. p$ M2 y
  F' J% w' T) Z5 z. j3 @http://www.reuters.com/article/2014/10/29/us-health-ebola-outcomes-idUSKBN0II2DG20141029
  ?$ }. j6 e4 h' S7 l5 d7 }/ S4 {! D1 s: Z0 V+ J

( y+ e# b3 Z% S/ |: u' I3 I( P
/ T6 Z+ n% R7 k( R; ~+ O# r+ V' DWho Survives Ebola? Analysis Of First Cases In Sierra Leone Reveals InsightsReuters; P$ \' n8 r2 ?% Q0 ~+ j
' i$ o7 ~1 y' |3 s8 Z) l4 O9 @

. X% F0 H3 [! V5 D' B+ N7 m6 dPosted: 10/29/2014 4:58 pm EDT Updated: 10/29/2014 5:59 pm EDT8 {9 c# D& o: Y- ]+ I, H( D

8 Z4 t# c5 m4 }& ]

" j, C/ |( s  T" p) P( k% W
5 v3 q/ A  {( c8 }, ^, t6 D0 [

, C8 A' W! |7 a
; N* k7 {4 X# Q. t2 z! x9 X! w  r2 F; n. c" V, L6 E; w

' ]8 h5 F$ V2 D' M* i- l4 C# t9 h9 G$ u: @! M, I$ N+ C
  |; c5 E7 h$ m5 r* @/ j, [
  e8 E5 G) I/ G6 @. Q
By Julie Steenhuysen* _) c  t# Z& M2 k3 ~) b' p7 Y
6 |2 ^2 g2 x/ w4 w) {
CHICAGO, Oct 29 (Reuters) - An analysis of the first Ebola cases in Sierra Leone helps draw a clearer picture of why some people survive the disease, while others do not, including their age and the pace at which the virus replicates within their body.' q. _2 |- c% L' ]1 g- o
  j* g3 G# ~7 f- p7 X' z. X) z
The study published Wednesday is based on data gathered from 106 patients diagnosed with Ebola at the Kenema Government Hospital in Sierra Leone from May 25 to July 18. Some of the data on this group was incinerated because of fears that the nurses' station where the records were kept became contaminated.
# j: @& ?: _. Z* ^: l! v
- q) T5 w& b  u. Y4 w& q- Y1 EBut the team managed to analyze detailed clinical records from a total of 44 Ebola patients, the biggest trove yet from the outbreak in West Africa that has killed nearly 5,000 people.
) P& c+ H% Q* D
* j7 k1 K" v; ^"This is the first time anybody has had this much data collected on any Ebola patients," said Dr. John Schieffelin of Tulane University in New Orleans, an author of the study published in the New England Journal of Medicine.
4 ?4 Y* k0 ~4 l1 V$ |! y
$ ?& t4 h' V' Y, |He said the findings help confirm some of the observations seen by doctors treating patients with Ebola.
% k1 _/ x6 g4 r7 C& a8 o" B6 I* H! ~/ T+ ~0 w
It shows, for example, that 57 percent of people under age 21 who were treated for Ebola died from their infections, compared with 94 percent of those over the age of 45.
8 _! G- @8 R# X/ M6 N2 ]# u4 ~4 i' V: [& C) w  @/ l& j
In the cases studied, the virus took six to 12 days to incubate before patients developed symptoms, and 74 percent of the patients in the study died, similar to what has been seen in prior outbreaks.
( I2 [; C  O2 K/ }2 u- F
" }4 J. `/ a+ ]: i- qFever was the most common symptom, occurring in 89 percent of patients, followed by headache (80 percent), weakness (66 percent), dizziness (60 percent) diarrhea (51 percent), abdominal pain (40 percent) and vomiting (34 percent).
9 h8 h+ S1 C1 t) `7 c& \. K. J+ v: d
However, there were some big differences in how individual patients responded to the virus, Schieffelin said.
9 r. y+ Y2 N. T) h5 h4 U/ X% I( R5 M+ A4 x6 |  v5 H3 f. }
"There were people who had very mild cases, and there are people who have very severe cases and they go downhill quickly," he said.
$ V- t  L" h1 G" G* Z" H6 [  X3 s. p1 O0 |: J3 S  [7 `
One surprise was the significant difference in the amount of virus present in patients when they came in for treatment, a factor that affected whether or not they survived.
9 u% y# V3 T2 k' u1 N* H/ k
9 S8 |" j) v5 b" @; s; ^: A. ]# _For example, 33 percent of patients with less than 100,000 copies of the virus per milliliter of blood at diagnosis ultimately died, compared with 94 percent mortality in those whose had more than 10 million copies per milliliter.
+ U( Y! f. b% b0 K& D- L9 _3 s6 o, Y9 Q6 Q/ G5 ]  x
Among the various symptoms in this outbreak, Schieffelin said diarrhea is a "really big feature of it," suggesting that doctors treating Ebola patients need to be very aggressive in administering intravenous fluids.  b( b9 m# ?) C. }) u
9 F, f2 N7 j+ Q" o3 b/ K5 p9 `/ F
Bleeding, a key feature of Ebola in prior outbreaks, was rare among this population, with only 1 patient having this symptom, the study found.9 _$ Z. d  O! q" n6 k8 m
0 Z$ \( W9 K" L* y1 R
Some researchers have questioned the value of spending resources on studying Ebola during the outbreak rather than using those funds to help curb the epidemic directly. Schieffelin said the analysis offers important insights for healthcare workers fighting the current outbreak, including data that can be used to determine new treatment and diagnostic approaches. (Reporting by Julie Steenhuysen; Editing by Jonathan Oatis)
! S$ i9 i" P+ ~. T2 Z( k6 a* d% T4 R# |0 j

http://www.huffingtonpost.com/2014/10/29/survive-ebola-sierra-leone-cases-study_n_6070972.html

, u  A9 R5 ^; c! v& [, m: q: w) J
$ x# L5 h- n& ~. i

: p8 @8 A+ n) I  W: p
. k/ U" c. Z4 a9 J% s
已有 1 人评分威望 包包 收起 理由
细胞海洋 + 50 + 100 极好专题

总评分: 威望 + 50  包包 + 100   查看全部评分

Rank: 7Rank: 7Rank: 7

积分
13286 
威望
13286  
包包
34831  

论坛元老 精华勋章 金话筒 专家 优秀会员 优秀版主

17
发表于 2014-11-13 20:24 |显示全部帖子
埃博拉患者之福音?无国界医生组织尝试新疗法
8 i5 ]$ A+ ?$ W- s) \; c% z$ V5 c8 h+ O( m- w! j$ k3 ?
2014-11-13来源: 中国新闻网# F2 T6 B; m; y7 _" K4 e6 ?

% O/ `& c7 J' I+ i* G  O$ q
: n+ B! H2 k# f- O6 E! c6 u6 U  ) }6 `0 `, ?; l9 n) s* j, D" E
  中新网11月13日电 据外媒13日报道,埃博拉疫情持续肆虐,无国界医生组织(MSF)计划在西非的三个治疗中心开展新的临床试验。
- |1 p& l+ H4 P, G- U8 k- P/ g- a  报道称,在临床试验中,医疗小组将使用两种新的药物,并同时尝试血浆疗法。其目的是帮助病人度过关键的前14天。
9 s# E+ E4 |8 N2 `  无国界医生组织发言人表示,上述试验是与英国、法国和比利时研究人员联手开展的,以提高埃博拉患者的存活率。该发言人称其为“前所未有的大合作”,或能找到埃博拉的真正疗法。% D/ H8 P0 E2 h
  据世界卫生组织的最新统计数字,肆虐于西非地区的埃博拉病毒截至11月9日已导致5160人丧生,致死人数首破5000人大关。同时,确诊或疑似感染病例已超过14000个,其中塞拉利昂成为新增病例最多的国家。

Rank: 7Rank: 7Rank: 7

积分
13286 
威望
13286  
包包
34831  

论坛元老 精华勋章 金话筒 专家 优秀会员 优秀版主

18
发表于 2014-11-17 13:54 |显示全部帖子
世卫:当前有前景的埃博拉试验性药物有限
/ O/ @7 A1 @/ y2014-11-17 11:13:16 来源: 网易探索! n0 y, J( i8 q3 K6 {
  H: p( D- P5 ~0 R' C
核心提示:世卫组织近日在一份声明中表示,世卫及其合作伙伴已收到来自科学界的约120份埃博拉潜在药物建议,但其中诸多药物经测试后证明无法抵抗埃博拉病毒。
3 E( J6 j  k' m2 `: n) \世界卫生组织14日在日内瓦表示,由于供应不足及缺少临床数据支持,当前有前景的埃博拉试验性药物有限。' [% F9 }+ h- {; s
2 J6 a# n; ^5 c8 F" {$ j4 u
世卫组织于11日至12日针对埃博拉病毒试验性干预手段召开技术咨询会议,来自临床、制药、药物监管等领域的专家重点对埃博拉试验性药物、康复期全血和血浆疗法等干预手段进行了讨论与评估。. p! Y1 W+ M- s$ F& G7 ^2 A

; E6 f, s/ W" \; ?1 r  D/ z, q3 T- r4 v; O世卫组织14日在一份声明中表示,世卫及其合作伙伴已收到来自科学界的约120份埃博拉潜在药物建议,但其中诸多药物经测试后证明无法抵抗埃博拉病毒。针对部分埃博拉患者被转移至其他国家成功治愈的案例,世卫表示这些患者治愈率高的原因可能源自高标准护理,初步数据无法证明其他干预手段的有效性。
- j) s/ Q7 N$ w
4 f$ w: q$ T4 k9 ^# Q' Z7 I
- E/ I0 K; I, n. c9 m: c世卫组织埃博拉专家马丁·弗里德当天在日内瓦万国宫举行的记者会上表示,以ZMapp和小分子干扰核糖核酸(siRNA)为代表的试验性药物被证实在猴子试验中十分有效,不过目前各方无法大规模生产此类药物,相反其他供应较为充足的试验性药物却缺乏支持其安全性及有效性的基本临床数据。
9 u3 S8 I5 E( O* T& ]1 d3 D" H7 b  T# j
目前的供应管道中没有很多有前景的埃博拉药物,这点非常明确。我们必须成立工作组,在现有基础上审查药物并试图寻找支持性数据,”弗里德说。' T: M6 u+ e# I+ I0 T# N1 a

) g# Q& v6 m: q此外,世卫组织还说,基于康复期全血和血浆疗法的第一阶段临床试验已准备在疫情重灾区展开。不过弗里德表示,血液疗法临床试验的首要挑战在于获得安全的康复患者血液,但西非基础医疗设施安全采集、处理血液的能力有限。(来源:新华社 记者 张淼 刘美辰)

Rank: 7Rank: 7Rank: 7

积分
13286 
威望
13286  
包包
34831  

论坛元老 精华勋章 金话筒 专家 优秀会员 优秀版主

19
发表于 2014-11-18 09:32 |显示全部帖子
外媒:专家质疑抗埃博拉药物效用 或与环境有关; N* k' [0 h7 r  Q9 v$ j+ U
2014-11-17 11:33:52 来源:参考消息网 责任编辑:姜涛
, X, s7 y* i# T) q+ j核心提示:迄今为止,几名从西非地区撤离的病人接受了没有经过测试的药物的治疗,但是尚不清楚这些病人是因为这些药物还是因为西方更好的医疗条件而康复的。8 Q2 o4 d* y! T5 ?* k( }
参考消息网11月17日报道 外媒称,世界卫生组织11月14日说,计划在西非进行的试验性埃博拉药物的测试没有得到医学专家的全面支持,因为没有足够的证据表明这些药物有效。
# u( O" q- o) k; G  A4 j$ G据德新社11月14日报道,世卫组织官员马丁·弗里德说,现在只有少量真正有希望治疗埃博拉的药物,这令快速治疗埃博拉的希望破灭。1 }1 u% y" Y, _9 ?
医疗救援组织无国界医生11月13日宣布,该组织计划于12月在几内亚开始测试日本治疗流行性感冒的药物法匹拉韦,并将测试美国试验性抗病毒药物布林西多福韦,但地点待定。
0 \' q6 b( p* f; e3 I* z7 M& u无国界医生之所以选择这两种药物是因为如果测试结果奏效,这两种药物可以迅速大量供应。2 t% _% {& i: g
然而,一个为世卫组织提供建议的专家小组指出,就这两种药物而言,初步的数据显示它们抗击埃博拉病毒的效力有限。
4 |( p4 R' d% ?! Q5 O世卫组织说,尽管有些专家赞同无国界医生的做法,因为这两种药物可以大量供应因此先测试它们的效用,但也有人认为“可用性不是研究一种没有太多数据支持的药物的原因”。
0 b+ d9 r4 C! ]% n目前没有已证明有效并得到批准的治疗埃博拉的药物。自去年12月西非地区暴发埃博拉以来,已经有5000多人因此丧生。
4 A* I/ b0 ~% E5 w/ s其他类型的试验性药物包括TKM-Ebola和ZMapp,它们都显示出了更有希望的初步结果,但是这些药物的供应不足。+ J3 M% J  A5 S1 ~% S, [$ b
迄今为止,几名从西非地区撤离的病人接受了没有经过测试的药物的治疗,但是尚不清楚这些病人是因为这些药物还是因为西方更好的医疗条件而康复的。
8 z3 f& v1 m% w  O据德新社11月15日报道,刚果民主共和国政府11月15日说,该国现在没有埃博拉病毒,而这种传染病暴发的3个月过程中至少造成该国49人死亡。5 O! W# m6 T# }" x
卫生部长费利克斯·农比说,自10月4日以来,没有出现新的病例,但是他警告说:“这种传染病的终结,并不意味着我们完全脱离了危险。”
0 ]! [4 k9 z% o' G& O% I他说:“就像其他所有国家一样,刚果民主共和国仍然面临目前在西非肆虐的埃博拉病毒可能从外部传入的威胁。”
2 y8 z6 O! C) S; q6 x4 l9 i' S刚果民主共和国暴发的埃博拉疫情与在西非导致5000多人丧生的病毒并非同一种类型。

Rank: 7Rank: 7Rank: 7

积分
13286 
威望
13286  
包包
34831  

论坛元老 精华勋章 金话筒 专家 优秀会员 优秀版主

20
发表于 2014-11-18 09:44 |显示全部帖子
西非埃博拉疫区将试验3种疗法
7 m) `$ C/ b8 A
: ?. a% }8 [8 V' O0 r" R5 X$ x2 j3 A- k2014-11-15 00:00:00 来源: 北京青年报2 \) q$ t5 [  \% d
国际组织“无国界医生”13日说,定于12月开始在西非埃博拉疫区对3种试验性疗法进行临床试验,以期尽快研制出切实有效的治疗埃博拉药物。
* g$ J) ~% M4 \2 N- E& t& ]4 o  u0 U8 z5 q4 ~8 R
目前,针对埃博拉病毒的多种药物和疫苗仍处于研发过程中。“无国界医生”选出其中3种疗法,将在利比里亚和几内亚征得患者同意后进行临床试验。% [" p; i, P& `. y

& i; i' U- ~3 a其中,英国牛津大学研究人员负责在利比里亚首都蒙罗维亚测试抗病毒药物brincidofovir的临床效果;法国国家卫生和医学研究所负责在几内亚南部的盖凯杜地区测试抗病毒药物法匹拉韦(favipiravir)的临床效果;比利时安特卫普热带医学研究所负责在几内亚首都科纳克里测试一种利用埃博拉病毒感染者血浆的疗法。% P$ }  v' N* t7 g! Z

1 ]+ \1 _) }3 O; T' F“无国界医生”介绍,如果患者使用试验性药物能够存活两周,便可视为临床治疗有效。预计明年2月将获得第一批临床试验的结果。/ O6 u" D1 Q' _
( t3 R1 U' Q( C, l" @9 L+ c2 Y- o
世界卫生组织12日发布的最新埃博拉疫情报告显示,截至本月9日,疫情重灾区几内亚、利比里亚和塞拉利昂累计发现埃博拉确诊、疑似和可能感染病例共计14068例,其中死亡5147人。
2 k9 W' d) c# b
* B% X* W$ X! |" B/ f( g8 Z' _文/杨舒怡(新华社特稿)
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2024-6-2 16:10

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.